112 related articles for article (PubMed ID: 14631016)
1. Society for Neuroscience meeting. Pills and games help conquer fear.
Miller G
Science; 2003 Nov; 302(5649):1321. PubMed ID: 14631016
[No Abstract] [Full Text] [Related]
2. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
4. Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
Davis M; Ressler K; Rothbaum BO; Richardson R
Biol Psychiatry; 2006 Aug; 60(4):369-75. PubMed ID: 16919524
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
[TBL] [Abstract][Full Text] [Related]
6. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
7. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.
Kushner MG; Kim SW; Donahue C; Thuras P; Adson D; Kotlyar M; McCabe J; Peterson J; Foa EB
Biol Psychiatry; 2007 Oct; 62(8):835-8. PubMed ID: 17588545
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
10. Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies.
Javitt DC
Am J Psychiatry; 2013 Jul; 170(7):699-702. PubMed ID: 23820828
[No Abstract] [Full Text] [Related]
11. Mechanisms of exposure therapy: how neuroscience can improve psychological treatments for anxiety disorders.
McNally RJ
Clin Psychol Rev; 2007 Jul; 27(6):750-9. PubMed ID: 17292521
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.
Guastella AJ; Richardson R; Lovibond PF; Rapee RM; Gaston JE; Mitchell P; Dadds MR
Biol Psychiatry; 2008 Mar; 63(6):544-9. PubMed ID: 18179785
[TBL] [Abstract][Full Text] [Related]
13. Influence of ethanol withdrawal on fear memory: Effect of D-cycloserine.
Bertotto ME; Bustos SG; Molina VA; Martijena ID
Neuroscience; 2006 Nov; 142(4):979-90. PubMed ID: 16934411
[TBL] [Abstract][Full Text] [Related]
14. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
Hofmann SG; Smits JA; Rosenfield D; Simon N; Otto MW; Meuret AE; Marques L; Fang A; Tart C; Pollack MH
Am J Psychiatry; 2013 Jul; 170(7):751-8. PubMed ID: 23599046
[TBL] [Abstract][Full Text] [Related]
15. Effects of D-cycloserine on extinction of learned fear to an olfactory cue.
Weber M; Hart J; Richardson R
Neurobiol Learn Mem; 2007 May; 87(4):476-82. PubMed ID: 17275356
[TBL] [Abstract][Full Text] [Related]
16. A high-throughput clinical assay for testing drug facilitation of exposure therapy.
Rodebaugh TL; Levinson CA; Lenze EJ
Depress Anxiety; 2013 Jul; 30(7):631-7. PubMed ID: 23283838
[TBL] [Abstract][Full Text] [Related]
17. Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications.
Richardson R; Ledgerwood L; Cranney J
Learn Mem; 2004; 11(5):510-6. PubMed ID: 15466301
[TBL] [Abstract][Full Text] [Related]
18. Effects of REM deprivation and an NMDA agonist on the extinction of conditioned fear.
Silvestri AJ; Root DH
Physiol Behav; 2008 Jan; 93(1-2):274-81. PubMed ID: 17920644
[TBL] [Abstract][Full Text] [Related]
19. Selective increase in the extracellular D-serine contents by D-cycloserine in the rat medial frontal cortex.
Fujihira T; Kanematsu S; Umino A; Yamamoto N; Nishikawa T
Neurochem Int; 2007; 51(2-4):233-6. PubMed ID: 17662507
[TBL] [Abstract][Full Text] [Related]
20. Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.
Rothbaum BO
Am J Psychiatry; 2008 Mar; 165(3):293-6. PubMed ID: 18316423
[No Abstract] [Full Text] [Related]
[Next] [New Search]